(Q40852245)

24 September 2017

title

ABCG2 overexpression in patients with acute myeloid leukemia: Impact on stem cell transplantation outcome (English)

1 reference

24 September 2017

1 reference

acute myeloid leukemia

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26059733%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

Daniela Damiani

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26059733%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

author name string

Antonella Geromin

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26059733%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

Angela Michelutti

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26059733%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

Margherita Cavallin

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26059733%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

Alessandra Sperotto

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26059733%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

Renato Fanin

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26059733%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

publication date

9 June 2015

1 reference

American Journal of Hematology

24 September 2017

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26059733%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

volume

90

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26059733%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

issue

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26059733%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

page(s)

784-789

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26059733%20AND%20SRC:MED&resulttype=core&format=json

Drug therapy for acute myeloid leukemia

13 June 2020

cites work

1 reference

Attempts to optimize induction and consolidation treatment in acute myeloid leukemia: results of the MRC AML12 trial

21 January 2018

1 reference

How to manage high-risk acute myeloid leukemia

21 January 2018

1 reference

Age and acute myeloid leukemia

21 January 2018

1 reference

Allogeneic hematopoietic cell transplantation for adults with acute myeloid leukemia: myths, controversies, and unknowns

21 January 2018

1 reference

Expanded indications for allogeneic stem cell transplantation in patients with myeloid malignancies

21 January 2018

1 reference

Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet

21 January 2018

1 reference

Allogeneic hematopoietic cell transplantation for acute myeloid leukemia in first complete remission: have the indications changed?

21 January 2018

1 reference

The European LeukemiaNet AML Working Party consensus statement on allogeneic HSCT for patients with AML in remission: an integrated-risk adapted approach

21 January 2018

1 reference

NCI First International Workshop on The Biology, Prevention and Treatment of Relapse after Allogeneic Hematopoietic Cell Transplantation: report from the committee on prevention of relapse following allogeneic cell transplantation for hematologic ma

21 January 2018

1 reference

NCI First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation: report from the Committee on the Epidemiology and Natural History of Relapse following Allogeneic Cell Tr

21 January 2018

1 reference

Impact of cytogenetics risk on outcome after reduced intensity conditioning allo-SCT from an HLA-identical sibling for patients with AML in first CR: a report from the acute leukemia working party of EBMT.

21 January 2018

1 reference

Impact of FLT3 internal tandem duplication on the outcome of related and unrelated hematopoietic transplantation for adult acute myeloid leukemia in first remission: a retrospective analysis.

21 January 2018

1 reference

The role of half-transporters in multidrug resistance

21 January 2018

1 reference

MRP3, BCRP, and P-glycoprotein activities are prognostic factors in adult acute myeloid leukemia

21 January 2018

1 reference

21 January 2018

1 reference

Refinement of cytogenetic classification in acute myeloid leukemia: determination of prognostic significance of rare recurring chromosomal abnormalities among 5876 younger adult patients treated in the United Kingdom Medical Research Council trials.

21 January 2018

1 reference

Investigation of the freely available easy-to-use software 'EZR' for medical statistics

21 January 2018

1 reference

Allogeneic transplantation versus chemotherapy as postremission therapy for acute myeloid leukemia: a prospective matched pairs analysis

21 January 2018

1 reference

Validation and refinement of the Disease Risk Index for allogeneic stem cell transplantation

21 January 2018

1 reference

Significance of minimal residual disease before myeloablative allogeneic hematopoietic cell transplantation for AML in first and second complete remission

21 January 2018

1 reference

MDR1 and BCRP1 expression in leukemic progenitors correlates with chemotherapy response in acute myeloid leukemia

21 January 2018

1 reference

ABCG2: the key to chemoresistance in cancer stem cells?

21 January 2018

1 reference

ABCG2, a novel antigen to sort luminal progenitors of BRCA1- breast cancer cells.

21 January 2018

1 reference

Molecular pharmacology of ABCG2 and its role in chemoresistance

21 January 2018

1 reference

Breast cancer resistance protein in drug resistance of primitive CD34+38- cells in acute myeloid leukemia

21 January 2018

1 reference

ABCG2: a potential marker of stem cells and novel target in stem cell and cancer therapy

21 January 2018

1 reference

Sensitization of ABCG2-overexpressing cells to conventional chemotherapeutic agent by sunitinib was associated with inhibiting the function of ABCG2.

21 January 2018

1 reference

Lapatinib (Tykerb, GW572016) reverses multidrug resistance in cancer cells by inhibiting the activity of ATP-binding cassette subfamily B member 1 and G member 2

21 January 2018

1 reference

Nilotinib enhances the efficacy of conventional chemotherapeutic drugs in CD34⁺CD38⁻ stem cells and ABC transporter overexpressing leukemia cells

21 January 2018

1 reference

Afatinib enhances the efficacy of conventional chemotherapeutic agents by eradicating cancer stem-like cells

21 January 2018

1 reference

Tivozanib reverses multidrug resistance mediated by ABCB1 (P-glycoprotein) and ABCG2 (BCRP).

21 January 2018

1 reference

OSI-930 analogues as novel reversal agents for ABCG2-mediated multidrug resistance

21 January 2018

1 reference

Nilotinib (AMN107, Tasigna) reverses multidrug resistance by inhibiting the activity of the ABCB1/Pgp and ABCG2/BCRP/MXR transporters

21 January 2018

1 reference

Chemotherapeutic drug-induced ABCG2 promoter demethylation as a novel mechanism of acquired multidrug resistance

21 January 2018

1 reference

Cancer-testis antigen expression and its epigenetic modulation in acute myeloid leukemia

21 January 2018

1 reference

Hypomethylating drugs convert HA-1-negative solid tumors into targets for stem cell-based immunotherapy

21 January 2018

1 reference